Curing ALS? Thirteen companies developing new treatments in 2025

14 biotech podcasts to tune into in 2025

Is biotech M&A set to surge in 2025?

Are PD-1 and PD-L1 checkpoint inhibitors as good as we thought?

Venture capital co-creation: The next big thing in biotech investment?

Top biotech deals of December 2024

Ten first-in-class drugs on track for FDA approval in 2025

CRISPR: The gene editing tool changing the world (2025 update)

Singapore’s biotech scene: 7 companies leading the way in 2025

2025 predictions: Which trends are set to shape the biotech industry this year?

The in vivo revolution: How Interius, Umoja, and Vyriad are transforming CAR-T cell therapy

Fighting pain with non-opioid drugs

Von Willebrand disease: Star Therapeutics, Chugai and Band Therapeutics are breaking new ground

Ten drugs to watch in 2025: will these therapies become blockbusters?

The biggest private biotech investments in December 2024

What to look for in a biotech incubator

A surge in deals: GSK bets on ADC, neuro and fibrotic diseases to bolster drug development  

Six biotech companies leading the way in India

[Rebroadcast] The power of natural killer cells

When biotech makes Christmas miracles a reality

Looking at 2025 biotech trends with SoftBank Vision Fund

After decades of stagnation, is Japan’s biopharma industry set for an upswing?

AI + CRISPR: The explosive fusion that will redefine biotechnology

Ovarian cancer: BioNTech, Curelab, OvarianVax and more bring vaccines to the clinic

10 biotech companies to watch in 2025